Who has invested in MBrace Therapeutics?

TPG, Avidity Partners, Cowen Healthcare Investments, Venrock, Alta Partners are named among the investors backing MBrace Therapeutics.

MBrace Therapeutics Funding: $110M Raised, Series B (2023)

MBrace Therapeutics funding overview

MBrace Therapeutics is a Biotech company based in San Diego, California. MBrace Therapeutics has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2023. The round record for MBrace Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include TPG, Avidity Partners, Cowen Healthcare Investments, Venrock, Alta Partners. 5 distinct backers are named across the disclosed rounds.

MBrace Therapeutics at a glance

Total raised: $110M
Latest round: Series B
Latest round date: November 2023
Industry: Biotech
Headquarters: San Diego, California
Notable investors: TPG, Avidity Partners, Cowen Healthcare Investments, Venrock, Alta Partners

Frequently asked about MBrace Therapeutics funding

How much has MBrace Therapeutics raised?: MBrace Therapeutics has raised $110M in total disclosed funding across the rounds on record.
Who has invested in MBrace Therapeutics?: TPG, Avidity Partners, Cowen Healthcare Investments, Venrock, Alta Partners are named among the investors backing MBrace Therapeutics.
What was the latest MBrace Therapeutics funding round?: The most recent disclosed round is a Series B, announced in November 2023.
Where is MBrace Therapeutics based?: MBrace Therapeutics is based in San Diego, California.
What sector does MBrace Therapeutics operate in?: MBrace Therapeutics is tracked under Biotech from San Diego, California, with $110M in disclosed funding.
When did MBrace Therapeutics last raise?: The last disclosed MBrace Therapeutics round closed in November 2023 at Series B.

Every MBrace Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Diego at a similar stage.

MBrace Therapeutics Funding: $110M Raised, Series B (2023)

MBrace Therapeutics funding overview

MBrace Therapeutics at a glance

Frequently asked about MBrace Therapeutics funding

MBrace Therapeutics founders (1)

Companies related to MBrace Therapeutics (40)

Browse related funding lists (10)